Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

ASX:DUG
ASX:DUGSoftware

DUG Technology (ASX:DUG) Valuation: Assessing Recent Contract Wins and Capital Raise

DUG Technology (ASX:DUG) just gave markets plenty to talk about. In a double dose of news, the company announced the quotation of 436,738 new ordinary shares on the ASX, aimed at boosting liquidity and broadening its reach. Additionally, it secured the first purchase order from Petronas under a multi-year contract, with the overall value of the deal climbing higher than first expected. For investors keeping an eye on the tech sector, these moves signal a company actively expanding both its...
TSX:ORA
TSX:ORAMetals and Mining

Aura Minerals (TSX:ORA): Evaluating Valuation After Borborema Gold Mine Achieves Commercial Production

If you’ve been tracking Aura Minerals (TSX:ORA) lately, you likely noticed the recent excitement after the company announced it hit commercial production at its Borborema gold mine. With the mill now running above 80% of its design capacity and gold recoveries climbing past 90%, this moment marks a tangible boost for Aura’s future production profile. Investors watching for concrete signs that Aura can deliver on its ambitious growth promises finally have a new data point to factor into their...
NasdaqGM:AVDL
NasdaqGM:AVDLPharmaceuticals

Why The Story Around Avadel Pharmaceuticals Is Evolving After Recent Analyst and Market Updates

Avadel Pharmaceuticals recently saw its consensus analyst price target edge up slightly from $20.20 to $20.30, reflecting a largely steady outlook. This minimal change is rooted in a balance between optimism over Lumryz’s commercial momentum and lingering concerns about ongoing competition in the sleep disorder market. Read on to discover how you can stay informed about ongoing shifts in the stock's narrative as new developments unfold. What Wall Street Has Been Saying Analyst commentary on...
NasdaqGS:CLBT
NasdaqGS:CLBTSoftware

How the Narrative Surrounding Cellebrite Is Shifting Amid Federal Delays and Future Catalysts

Cellebrite DI's consensus analyst price target has seen a modest uptick, rising from $22.57 to $23.14 despite several headwinds. While lingering softness in the U.S. federal market and revised revenue estimates have tempered enthusiasm, analysts attribute much of this to deal timing delays rather than a loss of demand. Stay tuned to find out how you can track ongoing developments in Cellebrite DI's evolving story. What Wall Street Has Been Saying Analyst coverage of Cellebrite DI reflects a...
TSX:SVM
TSX:SVMMetals and Mining

What Catalysts Are Changing the Story for Silvercorp Metals Now?

Silvercorp Metals stock has recently seen its consensus analyst price target rise from CA$8.38 to CA$8.76, reflecting a renewed sense of optimism among market watchers. This uptick is driven by expectations of production growth, leverage to stronger silver prices, and the upcoming diversification of assets. Read on to discover how you can follow these evolving developments and stay informed about Silvercorp Metals’ shifting narrative. What Wall Street Has Been Saying Analyst coverage of...
XTRA:NOEJ
XTRA:NOEJMachinery

NORMA Group (XTRA:NOEJ) Is Down 7.9% After Cutting 2025 Sales Forecast Following Water Unit Sale – Has The Bull Case Changed?

On September 23, 2025, NORMA Group SE issued revised earnings guidance, lowering its expected group sales from continuing operations for the year to approximately €810 million to €830 million, down from its previous estimate, which included Water Management, of around €1.1 billion to €1.2 billion. This updated forecast reflects NORMA Group’s realignment of its business focus and the anticipated effects of its divestment of the Water Management unit, offering insight into management’s current...
OM:ARJO B
OM:ARJO BMedical Equipment

Arjo (OM:ARJO B): Exploring Valuation Opportunities After a Quiet Period in Share Price Movement

There has not been a particular event sending shockwaves through Arjo (OM:ARJO B) shares this week, but sometimes a quieter period can be just as interesting. Investors keeping an eye on the medical technology maker may be wondering if recent market movements signal something deeper, such as shifting expectations for growth or profitability. Valuation becomes an important consideration, especially as the company continues to recalibrate in a changing healthcare environment. Taking a step...
TSX:BDI
TSX:BDICommercial Services

3 TSX Growth Stocks With Up To 24% Insider Ownership

As the Canadian market navigates a period of uncertainty, with central banks offering limited guidance on future policy moves, investors are closely monitoring economic indicators and their impact on major indices. In this environment of potential volatility, growth companies with high insider ownership can be particularly appealing due to the alignment of interests between company insiders and shareholders.
TSX:DC.A
TSX:DC.AMetals and Mining

Canadian Hidden Treasures And 2 More Small Caps With Strong Potential

As the Canadian market navigates through a period of ambiguity with central banks offering limited forward guidance, investors are closely monitoring economic indicators for signs of potential interest rate cuts. In this environment, small-cap stocks can present unique opportunities for growth, especially those that demonstrate resilience and adaptability amid market volatility. Identifying these hidden treasures requires a keen eye for companies with strong fundamentals and the ability to...
NasdaqGS:PFIS
NasdaqGS:PFISBanks

Exploring 3 Undervalued Small Caps With Insider Buying In The Global Market

As the U.S. stock market experiences a downturn led by declines in tech shares, small-cap stocks present an intriguing opportunity for investors navigating the current economic landscape shaped by recent Federal Reserve rate cuts. In this environment, identifying small-cap companies with strong fundamentals and insider buying can be key to uncovering potential value amidst broader market fluctuations.
NasdaqCM:ASPI
NasdaqCM:ASPIChemicals

September 2025's Top Growth Companies With Insider Influence

In September 2025, U.S. stock markets have experienced a downturn, with major indices like the Dow Jones Industrial Average, S&P 500, and Nasdaq all closing lower due to declines in tech shares following Federal Reserve Chair Jerome Powell's comments on interest rates. Amidst this backdrop of fluctuating market conditions and high valuations, growth companies with significant insider ownership can offer a unique perspective on potential resilience and strategic direction in uncertain times.
NasdaqCM:MVST
NasdaqCM:MVSTMachinery

Spotlight On Top Penny Stocks In September 2025

As of late September 2025, the U.S. stock market has experienced a downturn, with major indices such as the Dow Jones Industrial Average, S&P 500, and Nasdaq closing lower due to declines in tech stocks following comments from Federal Reserve Chair Jerome Powell. Amidst these broader market movements, investors often look for opportunities that offer potential growth at lower price points. Penny stocks—though an older term—still represent a compelling investment area by highlighting smaller...